KRW 6560.0
(-4.51%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -15.03 Billion KRW | -370.49% |
2022 | 5.55 Billion KRW | 88.37% |
2021 | 2.95 Billion KRW | 251.02% |
2020 | -1.95 Billion KRW | -29.74% |
2019 | -1.5 Billion KRW | 50.77% |
2018 | -3.05 Billion KRW | -268.87% |
2017 | 1.81 Billion KRW | 493.21% |
2016 | -460.59 Million KRW | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | -2.81 Billion KRW | 81.31% |
2024 Q2 | -8.58 Billion KRW | -205.65% |
2023 Q4 | -15.03 Billion KRW | -707.67% |
2023 FY | -15.03 Billion KRW | -370.49% |
2023 Q3 | -1.86 Billion KRW | -918.51% |
2023 Q2 | -182.74 Million KRW | -109.57% |
2023 Q1 | 1.9 Billion KRW | -65.64% |
2022 Q2 | -35.82 Billion KRW | -1087.81% |
2022 Q1 | 3.62 Billion KRW | 22.94% |
2022 Q3 | 5.37 Billion KRW | 115.01% |
2022 Q4 | 5.55 Billion KRW | 3.34% |
2021 Q4 | 2.95 Billion KRW | 12.86% |
2021 Q3 | 2.61 Billion KRW | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Osang Healthcare Co.,Ltd | -108.91 Billion KRW | 86.198% |
InBody Co.,Ltd | -16.2 Billion KRW | 7.239% |
Seegene, Inc. | -48.57 Billion KRW | 69.054% |
i-SENS, Inc. | 98.45 Billion KRW | 115.268% |
Ray Co., Ltd. | 67.09 Billion KRW | 122.405% |
Gencurix Inc. | 15.02 Billion KRW | 200.049% |
Sugentech Inc. | -6.95 Billion KRW | -116.25% |
L&C Bio Co., Ltd | 67.18 Billion KRW | 122.375% |